Efficacy and Safety of Leningrado 5 Association in the Treatment of Hypertension

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

September 30, 2020

Conditions
Arterial Hypertension
Interventions
DRUG

LENINGRADO 5 association

1 coated sustained-release tablet, oral, once a day.

DRUG

Natrilix® SR

1 coated sustained-release tablet, oral, once a day.

OTHER

Natrilix SR Placebo

1 coated sustained-release tablet, oral, once a day.

OTHER

Leningrado 5 association Placebo

1 coated sustained-release tablet, oral, once a day.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EMS

INDUSTRY

NCT03814148 - Efficacy and Safety of Leningrado 5 Association in the Treatment of Hypertension | Biotech Hunter | Biotech Hunter